CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹2,837 Cr | ₹2,474 Cr | ₹2,535 Cr | ₹2,508 Cr | ₹2,067 Cr |
What is the latest Trade Payables ratio of CIPLA ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹2,837 Cr |
| Mar2024 | ₹2,474 Cr |
| Mar2023 | ₹2,535 Cr |
| Mar2022 | ₹2,508 Cr |
| Mar2021 | ₹2,067 Cr |
How is Trade Payables of CIPLA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,837 Cr | 14.69 | |
| Mar2024 | ₹2,474 Cr | -2.39 | |
| Mar2023 | ₹2,535 Cr | 1.05 | |
| Mar2022 | ₹2,508 Cr | 21.35 | |
| Mar2021 | ₹2,067 Cr | - | |
Compare Trade Payables of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,502.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
| MANKIND PHARMA | ₹85,019.3 Cr | -0.4% | -10.9% | -16.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.5% |
-9.3% |
-7.3% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses